As highly-multiplexed tissue imaging continues to demonstrate its potential for drug development, Propath now offers a comprehensive service for ultra-high plex immunofluorescence.
The COMETTM is a high-throughput automated immunofluorescence staining platform, enabling imaging of up to 40 protein targets from a single tissue section.
The platform allows multiplexing with standard antibody libraries, with no conjugated or barcoding needed.
Using a sequential IF (seqIFTM) approach means that highly multiplexed panels can be developed in days – not months – with high tissue preservation and signal stability.
As the only high-throughput solution available currently for hyperplex immunofluorescence staining, the COMETTM offers several advantages:
A significant advantage of the COMET is that the system is open for use with commercially available, non-conjugated, primary antibodies, although Propath can provide a list of suggested markers and clones that have been tested and optimised.
We are also able to use clients’ existing validated library of antibodies to develop hyper-plex assays within days.
Alternatively clients may start with one of Propath’s modular pre-optimised panels, with the option to add additional markers easily.
COMET is designed to deliver maximum throughput for high-plex assays. We are able to process up to 20 slides of 20-plex per week; and 12 slides of 20-plex per week.
9 x 9 mm.
It is possible to select a smaller Region of Interest to reduce the final file size. However, this will not reduce the overall protocol time as the parallelized staining takes approximately the same amount of time.
The output format is TIFF and/or OME-TIFF files.